Kelliny, Sally http://orcid.org/0000-0003-3181-0279
Bobrovskaya, Larisa http://orcid.org/0000-0002-5793-6147
Zhou, Xin-Fu http://orcid.org/0000-0002-8687-0175
Upton, Richard http://orcid.org/0000-0001-9996-4886
Funding for this research was provided by:
National Health and Medical Research Council (APP1020567, APP1021409)
Commonwealth Research and Training scholarship
Ministry of Higher Education, Egypt
Article History
Accepted: 13 November 2020
First Online: 28 January 2021
Declarations
:
: This work was supported by NHMRC grants (APP1020567, APP1021409) and a supporting grant from the University of South Australia. The authors also acknowledge the support provided to S. Kelliny by a Commonwealth Research and Training scholarship and the Egyptian Ministry of Higher Education. p75ECD-Fc was provided by Fujian Tiantai Medical Technology Ltd.
: Xin-Fu Zhou is one of the inventors of p75ECD-Fc for the treatment of AD. The other authors declare no conflict of interest.
: All animal procedures performed in this study were approved by the Animal Ethics Committee (AEC) of the University of South Australia (approval number U14/16) and in compliance with the South Australian Animal Welfare Act 1985 and Regulations 2012.
: Not applicable.
: Not applicable.
: Data are available on negotiation with the authors.
: Code are available on negotiation with the authors.
: All authors participated in the study design and/or data interpretation. S.K. conducted the animal study and samples analysis. Statistical analysis, model development and evaluation were performed by R.U. and S.K. The first draft of the manuscript was written by S.K. and R.U. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.